Netflix - "The Bleeding Edge Documentary"

Thread Starter


Joined Jan 10, 2010
My Daughter is going for her Nursing Degree and wanted me to watch this on Netflix, I watched it this morning. It is chilling to know how the Medical Industry has changed, FDA is no longer the proof of Medical Devices, it's the industry who govern themselves and are willing to cast dice on your health. They provide the data and will change your views on paper during a study, if you say no I don't like this device or surgery etc. your voice is silenced for profits.

Far to many people have been injured or are still going through medical issues related to device implants.

Hip replacement using cobalt can deteriorate surrounding tissues and create rejection of the joint by the immune systems responses. Essure implants for sterilization,

Earlier this month, Bayer completed the $63 billion acquisition of St. Louis-based Monsanto Co., becoming the world’s biggest seed and agricultural chemicals maker. With its $1.42 billion purchase of Merck & Co.’s non-prescription drug line in 2014, the company became the world’s second-largest drugmaker behind Johnson & Johnson. It also has sold off its plastics business, and wants to get half its sales from health and half from agriculture.

Essure, created by Conceptus Inc. in 1998, was first approved for sale in the U.S. in 2002. The device features two metal coils implanted into a woman’s fallopian tubes during a regular doctor’s visit. Once the coils expand, they cause scar tissue to form which blocks the tubes.

Bayer bought Conceptus in 2013 for $1.1 billion to bolster its lineup of contraceptives. At the time, Leverkusen, Germany-based Bayer’s Yaz and Yasmin oral birth-control pills were falling because of competition from low-priced copies and suits over those products.
Many people on this site are respected, when you talk people listen, staying the know is your wheelhouse you can best provide information about things that the lower 80% of the population would listen and learn from.


Bayer denies safety flaws, but pulls device from U.S. market